Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) Gross Margin (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Gross Margin for 10 consecutive years, with 60.22% as the latest value for Q3 2025.

  • On a quarterly basis, Gross Margin fell 317.0% to 60.22% in Q3 2025 year-over-year; TTM through Sep 2025 was 62.32%, a 50.0% decrease, with the full-year FY2024 number at 63.4%, up 481.0% from a year prior.
  • Gross Margin was 60.22% for Q3 2025 at KORU Medical Systems, down from 63.52% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 65.0% in Q2 2024 to a low of 51.11% in Q2 2022.
  • A 5-year average of 59.44% and a median of 59.51% in 2021 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: plummeted -696bps in 2022, then soared 894bps in 2024.
  • KORU Medical Systems' Gross Margin stood at 59.04% in 2021, then decreased by -6bps to 55.53% in 2022, then increased by 9bps to 60.27% in 2023, then grew by 4bps to 62.94% in 2024, then dropped by -4bps to 60.22% in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Gross Margin are 60.22% (Q3 2025), 63.52% (Q2 2025), and 62.75% (Q1 2025).